Update on Turner and Noonan Syndromes

Elizabeth Chacko, Evan Graber, Molly O. Regelmann, Elizabeth Wallach, Gertrude Costin, Robert Rapaport

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Turner syndrome (TS) and Noonan syndrome (NS) have short stature as a constant feature; however, both conditions can present clinicians with a challenging array of genetic, cardiovascular, developmental, and psychosocial issues. In recent years, important advances have been achieved in each of these areas. This article reviews these two syndromes and provides updates on recent developments in diagnostic evaluation, growth and development, psychological issues, and treatment options for patients with TS and NS.

Original languageEnglish (US)
Pages (from-to)713-734
Number of pages22
JournalEndocrinology and Metabolism Clinics of North America
Volume41
Issue number4
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Noonan Syndrome
Turner Syndrome
Growth and Development
Psychology
Therapeutics

Keywords

  • Estrogen therapy
  • Growth
  • Noonan syndrome
  • Recombinant human growth hormone
  • Turner syndrome

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Update on Turner and Noonan Syndromes. / Chacko, Elizabeth; Graber, Evan; Regelmann, Molly O.; Wallach, Elizabeth; Costin, Gertrude; Rapaport, Robert.

In: Endocrinology and Metabolism Clinics of North America, Vol. 41, No. 4, 12.2012, p. 713-734.

Research output: Contribution to journalReview article

Chacko, E, Graber, E, Regelmann, MO, Wallach, E, Costin, G & Rapaport, R 2012, 'Update on Turner and Noonan Syndromes', Endocrinology and Metabolism Clinics of North America, vol. 41, no. 4, pp. 713-734. https://doi.org/10.1016/j.ecl.2012.08.007
Chacko, Elizabeth ; Graber, Evan ; Regelmann, Molly O. ; Wallach, Elizabeth ; Costin, Gertrude ; Rapaport, Robert. / Update on Turner and Noonan Syndromes. In: Endocrinology and Metabolism Clinics of North America. 2012 ; Vol. 41, No. 4. pp. 713-734.
@article{057d35aaceef427cafca14f11b0a6c26,
title = "Update on Turner and Noonan Syndromes",
abstract = "Turner syndrome (TS) and Noonan syndrome (NS) have short stature as a constant feature; however, both conditions can present clinicians with a challenging array of genetic, cardiovascular, developmental, and psychosocial issues. In recent years, important advances have been achieved in each of these areas. This article reviews these two syndromes and provides updates on recent developments in diagnostic evaluation, growth and development, psychological issues, and treatment options for patients with TS and NS.",
keywords = "Estrogen therapy, Growth, Noonan syndrome, Recombinant human growth hormone, Turner syndrome",
author = "Elizabeth Chacko and Evan Graber and Regelmann, {Molly O.} and Elizabeth Wallach and Gertrude Costin and Robert Rapaport",
year = "2012",
month = "12",
doi = "10.1016/j.ecl.2012.08.007",
language = "English (US)",
volume = "41",
pages = "713--734",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Update on Turner and Noonan Syndromes

AU - Chacko, Elizabeth

AU - Graber, Evan

AU - Regelmann, Molly O.

AU - Wallach, Elizabeth

AU - Costin, Gertrude

AU - Rapaport, Robert

PY - 2012/12

Y1 - 2012/12

N2 - Turner syndrome (TS) and Noonan syndrome (NS) have short stature as a constant feature; however, both conditions can present clinicians with a challenging array of genetic, cardiovascular, developmental, and psychosocial issues. In recent years, important advances have been achieved in each of these areas. This article reviews these two syndromes and provides updates on recent developments in diagnostic evaluation, growth and development, psychological issues, and treatment options for patients with TS and NS.

AB - Turner syndrome (TS) and Noonan syndrome (NS) have short stature as a constant feature; however, both conditions can present clinicians with a challenging array of genetic, cardiovascular, developmental, and psychosocial issues. In recent years, important advances have been achieved in each of these areas. This article reviews these two syndromes and provides updates on recent developments in diagnostic evaluation, growth and development, psychological issues, and treatment options for patients with TS and NS.

KW - Estrogen therapy

KW - Growth

KW - Noonan syndrome

KW - Recombinant human growth hormone

KW - Turner syndrome

UR - http://www.scopus.com/inward/record.url?scp=84867955990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867955990&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2012.08.007

DO - 10.1016/j.ecl.2012.08.007

M3 - Review article

C2 - 23099266

AN - SCOPUS:84867955990

VL - 41

SP - 713

EP - 734

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 4

ER -